A detailed history of Chicago Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, Chicago Capital, LLC holds 2,830 shares of NVS stock, worth $278,330. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,830
Previous 2,640 7.2%
Holding current value
$278,330
Previous $281,000 15.66%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$106.13 - $120.89 $20,164 - $22,969
190 Added 7.2%
2,830 $325,000
Q4 2022

Jan 20, 2023

SELL
$75.55 - $92.52 $56,662 - $69,390
-750 Reduced 22.12%
2,640 $0
Q4 2021

Jan 20, 2022

BUY
$79.7 - $88.13 $59,775 - $66,097
750 Added 28.41%
3,390 $297,000
Q4 2019

Jan 14, 2020

SELL
$84.35 - $95.37 $22,099 - $24,986
-262 Reduced 9.03%
2,640 $250,000
Q2 2019

Jul 11, 2019

SELL
$75.4 - $92.8 $3,770 - $4,640
-50 Reduced 1.69%
2,902 $265,000
Q4 2018

Feb 11, 2019

SELL
$73.66 - $82.02 $7,366 - $8,202
-100 Reduced 3.28%
2,952 $253,000
Q3 2018

Nov 02, 2018

SELL
$66.94 - $77.43 $12,049 - $13,937
-180 Reduced 5.57%
3,052 $263,000
Q2 2018

Jul 19, 2018

BUY
$64.91 - $73.36 $209,789 - $237,099
3,232 New
3,232 $244,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Chicago Capital, LLC Portfolio

Follow Chicago Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.